5-氯-8-喹啉三氟甲磺酸酯 | 157437-38-2

• 物质功能分类: 医药中间体 - 杂环化合物 - 喹啉类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 5-氯-8-喹啉三氟甲磺酸酯
• 中文别名: 5-氯-8-喹啉三氟甲磺酸
• 英文名称: 5-chloroquinolin-8-yl trifluoromethanesulfonate
• 英文别名: 5-Chloro-8-quinolinetrifluoromethanesulfonate；(5-chloroquinolin-8-yl) trifluoromethanesulfonate
• CAS: 157437-38-2
• 化学式: C₁₀H₅ClF₃NO₃S
• 分子量: 311.669
• InChiKey: ICTAEAXUAWQHSL-UHFFFAOYSA-N

物化性质

• 熔点：
  79-83 °C(lit.)
• 稳定性/保质期：
  在常温常压下保持稳定，应避免与强氧化剂接触。

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  64.6
• 氢给体数：
  0
• 氢受体数：
  7

安全信息

• 危险品标志：
  T
• 危险类别码：
  R25
• 危险品运输编号：
  UN 2811 6.1/PG 3
• WGK Germany：
  3
• 安全说明：
  S26
• 储存条件：
  密封存储于阴凉干燥的库房中。

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 5-Chloro-8-quinolinetrifluoromethanesulfonate
CAS-No. : 157437-38-2

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Acute toxicity, Oral (Category 1)
Skin irritation (Category 2)
Eye irritation (Category 2)
Specific target organ toxicity - single exposure (Category 3)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Irritating to eyes, respiratory system and skin. Toxic if swallowed.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal word Danger
Hazard statement(s)
Fatal if swallowed.
Causes skin irritation.
Causes serious eye irritation.
May cause respiratory irritation.
Precautionary statement(s)
Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
Wash hands thoroughly after handling.
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/
physician.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R36/37/38 Irritating to eyes, respiratory system and skin.
R25 Toxic if swallowed.
S-phrase(s)
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
S36/37 Wear suitable protective clothing and gloves.
S45 In case of accident or if you feel unwell, seek medical advice immediately
(show the label where possible).
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Synonyms : 5-Chloro-8-quinolinetriflate
Formula : C10H5ClF3NO3S
Molecular Weight : 311,66 g/mol
Component Concentration
5-Chloro-8-quinolinetrifluoromethanesulfonate
CAS-No. 157437-38-2 -

---

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx), Sulphur oxides, Hydrogen chloride gas, Hydrogen fluoride
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Wear respiratory protection. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure adequate
ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling
the product.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle
respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering
controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use
respirators and components tested and approved under appropriate government standards such
as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 79 - 83 °C - lit.
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 2,689
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation.
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. Causes respiratory tract irritation.
Ingestion May be fatal if swallowed.
Skin May be harmful if absorbed through skin. Causes skin irritation.
Eyes Causes serious eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: 2811 IMDG: 2811 IATA: 2811
UN proper shipping name
ADR/RID: TOXIC SOLID, ORGANIC, N.O.S. (5-Chloro-8-quinolinetrifluoromethanesulfonate)
IMDG: TOXIC SOLID, ORGANIC, N.O.S. (5-Chloro-8-quinolinetrifluoromethanesulfonate)
IATA: Toxic solid, organic, n.o.s. (5-Chloro-8-quinolinetrifluoromethanesulfonate)
Transport hazard class(es)
ADR/RID: 6.1 IMDG: 6.1 IATA: 6.1
Packaging group
ADR/RID: III IMDG: III IATA: III
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-氯-8-喹啉三氟甲磺酸酯 在 硫酸 、 potassium carbonate 作用下， 以 水 、 甲苯 为溶剂， 反应 17.33h， 生成 8-Bromo-5-chloroindeno[2,1-h]quinolin-7-one
  参考文献：
  名称：

  一种蓝光掺杂材料、其制备方法及有机电致发 光器件

  摘要：

  本发明涉及一种蓝光掺杂材料、其制备方法及有机电致发光器件，其中的蓝光掺杂材料如下式I所示，在下式I中，X为氧、硫或不存在，Ar1与Ar2为芳基、稠环芳烃基或芳族杂环基中的任意一种，所述Ar1与Ar2相同或不同。该材料不仅具有合适的HOMO及LUMO能级，从而具有良好的空穴传输性能，同时还具有较高的成膜性以及稳定性，因此能够作为蓝光掺杂材料应用在有机电致发光器件中。

  公开号：

  CN105924395B
• 作为产物：
  描述：

  5-氯-8-羟基喹啉 生成 5-氯-8-喹啉三氟甲磺酸酯
  参考文献：
  名称：

  Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds

  摘要：

  本发明涉及一种新型的香农酰胺化合物，可用于治疗炎症和免疫性疾病，包括含有这些化合物的药物组合物，以及在哺乳动物体内抑制炎症或抑制免疫反应的方法。

  公开号：

  US06878700B1

文献信息

• Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor
  申请人：Asselin Magda

  公开号：US20070027160A1

  公开（公告）日：2007-02-01

  The present invention relates to novel piperazine-piperidine compounds. The compounds are useful as 5-HT 1A binding agents, particularly as 5-HT 1A receptor antagonists and agonists. These compounds are useful in treating central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction.

  本发明涉及新型哌嗪-哌啶化合物。这些化合物可用作5-HT1A结合剂，特别是作为5-HT1A受体拮抗剂和激动剂。这些化合物在治疗中枢神经系统疾病方面很有用，如认知障碍、焦虑症、抑郁症和性功能障碍。
• A Next‐Generation Air‐Stable Palladium(I) Dimer Enables Olefin Migration and Selective C−C Coupling in Air
  作者：Gourab Kundu、Theresa Sperger、Kari Rissanen、Franziska Schoenebeck

  DOI：10.1002/anie.202009115

  日期：2020.12

  We report a new air‐stable PdI dimer, [Pd(μ‐I)(PCy2tBu)]2, which triggers E‐selective olefin migration to enamides and styrene derivatives in the presence of multiple functional groups and with complete tolerance of air. The same dimer also triggers extremely rapid C−C coupling (alkylation and arylation) at room temperature in a modular and triply selective fashion of aromatic C−Br, C−OTf/OFs, and

  我们报告了一种新的空气稳定的Pd I二聚体[Pd（μI）（PCy 2 t Bu）] 2，它在存在多个官能团且具有完全耐受性的情况下触发E-选择性烯烃向酰胺和苯乙烯衍生物的迁移空气 同一二聚体还可以在室温下以模块化和三重选择性的方式在聚（假）卤代芳烃中以芳族C-Br，C-OTf / OF和C-Cl键的形式快速触发C-C偶联（烷基化和芳基化）在具有邻位C-OTf的取代基的底物上显示出比以前的Pd I二聚体更好的活性。
• BENZOFURANYL- AND BENZOTHIENYL- PIPERAZINYL QUINOLINES AND METHODS OF THEIR USE
  申请人：Venkatesan Aranapakam Mudumbai

  公开号：US20090054454A1

  公开（公告）日：2009-02-26

  Benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives and compositions containing such compounds are disclosed. Methods of using benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives and compositions containing such composition in the treatment and/or prevention of serotonin-related disorders, such as depression and anxiety, are also disclosed. In addition, processes for the preparation of benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives are disclosed.

  本专利揭示了苯并呋喃基和苯并噻吩基哌嗪喹啉衍生物以及含有这些化合物的组合物。还揭示了使用苯并呋喃基和苯并噻吩基哌嗪喹啉衍生物以及含有这种组合物在治疗和/或预防与5-羟色胺相关的疾病，如抑郁症和焦虑症的方法。此外，还揭示了制备苯并呋喃基和苯并噻吩基哌嗪喹啉衍生物的方法。
• Highly stereoselective and catalytic desulfitative C O and C I dienylation with sulfolenes: The importance of basic additives
  作者：Hang T. Dang、Viet D. Nguyen、Hoang H. Pham、Hadi D. Arman、Oleg V. Larionov

  DOI：10.1016/j.tet.2019.04.012

  日期：2019.6

  organic synthesis and materials science. We describe herein a palladium-catalyzed dienylation of aryl, heteroaryl, and vinyl triflates, nonaflates and iodides that were previously identified as recalcitrant substrates for the sulfolene-mediated catalytic dienylation. The method has now been successfully expanded to C-O and C-I dienylation, demonstrating broad scope with respect to sulfonates, iodides

  共轭二烯和多烯是天然产物的中心结构图案，也是有机合成和材料科学中的关键合成中间体。我们在本文中描述了芳基，杂芳基和乙烯基三氟甲磺酸酯，壬二酸酯和碘化物的钯催化的二烯基化，这些化合物先前已被确定为环丁二烯介导的催化二烯基化的顽固底物。该方法现已成功扩展到CO和CI二烯基化，在磺酸盐，碘化物和亚砜方面具有广阔的应用前景。反应进行时具有很高的区域选择性和立体选择性，并且效率受到碱性添加剂的强烈影响，因此系统地研究了其对反应性能的影响。
• Modular Functionalization of Arenes in a Triply Selective Sequence: Rapid C(sp² ) and C(sp³ ) Coupling of C−Br, C−OTf, and C−Cl Bonds Enabled by a Single Palladium(I) Dimer
  作者：Sinead T. Keaveney、Gourab Kundu、Franziska Schoenebeck

  DOI：10.1002/anie.201808386

  日期：2018.9.17

  competing coupling sites would enable straightforward access to densely functionalized compound libraries. Historically, the site selection in Pd0‐catalyzed functionalizations of poly(pseudo)halogenated arenes has been unpredictable, being dependent on the employed catalyst, the reaction conditions, and the substrate itself. Building on our previous report of C−Br‐selective functionalization in the presence

  对多个竞争偶联位点的完全控制将能够直接访问密集功能化的化合物库。历史上，Pd 0催化的多（拟）卤代芳烃官能化的位点选择是不可预测的，取决于所使用的催化剂、反应条件和底物本身。基于我们之前在 C−OTf 和 C−Cl 键存在下的 C−Br 选择性官能化报告，我们在此完成了序列并演示了 C−OTf 键的第一个一般芳基化和烷基化（以 <10 分钟为单位），然后在室温下使用相同的空气和湿度稳定的 Pd 二聚体对 C−Cl 位点进行功能化（在 <25 分钟内）。这使得实现了 C−Br、C−OTf 和 C−Cl 键的第一个通用和三重选择性连续 C−C 耦合（在 2D 和 3D 空间中）。